Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
97,714.05
(1.3%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Microba Life Sciences Ltd

MAP

ASX

Microba Life Sciences Limited is a precision microbiome company with leading technology developed at the University of Queensland. Microba provide its gut microbiome testing services globally through two service types - Personal Testing and Research Testing.

Latest Posts

Line Chart with Gradient
Price
$0.170
0.01 (6.25%)
At Close 22/11 (AEST)
Related Companies
LBT INNOVATIONS LIMITED
$LBT
BEAMTREE HOLDINGS LIMITED
$BMT
IMEXHS LIMITED
$IME
ANSELL LIMITED
$ANN
RAMSAY HEALTH CARE LIMITED
$RHC

Leave a Comment on MAP


Comments for MAP

    Latest Posts

    microba-life-sciences-asx-map-receives-rd-tax-incentive-refund-map
    Health Care $MAP
    Microba Life Sciences (ASX: $MAP) receives R&D tax incentive refundSecures $6M refund boosting financial strength for microbiome diagnostics and therapeutics
    November 18, 2024
    microba-life-sciences-asx-map-completes-autoimmune-program-with-ginkgo-bioworks-map
    Health Care $MAP

    Microba Life Sciences (ASX: $MAP) completes autoimmune program with Ginkgo Bioworks

    6 lead strains with compelling disease-relevant activity selected for further development

    June 28, 2024
    microba-life-sciences-asx-map-presents-q3-fy24-investor-presentation-map
    Health Care $MAP

    Microba Life Sciences (ASX: $MAP) presents Q3 FY24 investor presentation

    Delivers strong Q3 results and advances precision microbiome therapeutics

    April 24, 2024
    microba-life-sciences-asx-map-reports-strong-q3-fy24-revenue-growth-map
    Health Care $MAP

    Microba Life Sciences (ASX: $MAP) reports strong Q3 FY24 revenue growth

    Launches world-first pathogen test, MetaPanel, in Australia and delivers first full quarter of sales from UK acquisition

    April 24, 2024
    microba-life-sciences-asx-map-receives-6-08-million-rd-tax-incentive-refund-map
    Health Care $MAP

    Microba Life Sciences (ASX: $MAP) receives $6.08 million r&d tax incentive refund

    Australian company receives significant tax incentive for research & development activities

    April 10, 2024
    microba-life-sciences-asxmap-announces-successful-phase-i-clinical-trial-map
    Health Care $MAP

    Microba Life Sciences (ASX:MAP) announces successful phase i clinical trial

    Lead drug candidate MAP 315 demonstrates strong safety and tolerability profile for ulcerative colitis treatment

    December 19, 2023

    MAP

    $MAP

    Microba Life Sciences (ASX: $MAP) receives R&D tax incentive refund

    Secures $6M refund boosting financial strength for microbiome diagnostics and therapeutics

    MAP

    $MAP

    Microba Life Sciences (ASX: $MAP) completes autoimmune program with Ginkgo Bioworks

    6 lead strains with compelling disease-relevant activity selected for further development

    MAP

    $MAP

    Microba Life Sciences (ASX: $MAP) presents Q3 FY24 investor presentation

    Delivers strong Q3 results and advances precision microbiome therapeutics

    MAP

    $MAP

    Microba Life Sciences (ASX: $MAP) reports strong Q3 FY24 revenue growth

    Launches world-first pathogen test, MetaPanel, in Australia and delivers first full quarter of sales from UK acquisition

    MAP

    $MAP

    Microba Life Sciences (ASX: $MAP) receives $6.08 million r&d tax incentive refund

    Australian company receives significant tax incentive for research & development activities

    MAP

    $MAP

    Microba Life Sciences (ASX:MAP) announces successful phase i clinical trial

    Lead drug candidate MAP 315 demonstrates strong safety and tolerability profile for ulcerative colitis treatment

    Related Companies
    BEAMTREE HOLDINGS LIMITED
    $BMT
    AUSTCO HEALTHCARE LIMITED
    $AHC
    MEDADVISOR LIMITED
    $MDR
    HEALIUS LIMITED
    $HLS
    AUSTRALIAN CLINICAL LABS LIMITED
    $ACL

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions